Genomic features beyond Chlamydia trachomatis phenotypes: What do we think we know?

被引:23
|
作者
Nunes, Alexandra [1 ]
Borrego, Maria J. [1 ]
Gomes, Joao P. [1 ]
机构
[1] Natl Inst Hlth, Dept Infect Dis, P-1649016 Lisbon, Portugal
关键词
Chlamydia trachomatis; Recombination; Point-mutation; Tissue tropism; Pathogenesis; Ecological success; OUTER-MEMBRANE PROTEIN; OBLIGATE INTRACELLULAR PATHOGEN; IN-VIVO; TISSUE TROPISM; GLYCOSAMINOGLYCAN BINDING; SALMONELLA-TYPHIMURIUM; TRYPTOPHAN SYNTHASE; DEVELOPMENTAL CYCLE; HOST-CELLS; GENE DECAY;
D O I
10.1016/j.meegid.2013.03.018
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The obligate intracellular pathogen Chlamydia trachomatis is the causative agent of the blinding trachoma and the world's leading cause of bacterial sexually transmitted infections. Despite aggressive antibacterial control measures, C trachomatis infections have been increasing, constituting a serious public health concern due to its morbidity and socioeconomic burden. Still, very little is known about the molecular basis underlying the phenotypic disparities observed among C trachomatis serovars in terms of tissue tropism (ocular conjunctiva, epithelial-genitalia and lymph nodes), virulence (disease outcomes) and ecological success. This is in part due to the inexistence of straightforward tools to genetically manipulate Chlamydiae and host cell-free growth systems, hampering the elucidation of the biological role of loci. The recent release of tenths of full-genome C trachomatis sequences depict a strains clustering scenario reflecting the organ/cell-type that they preferentially infect. However, the high degree of genomic conservation implies that few genetic features are involved in phenotypic dissimilarities. The purpose of this review is to gather the most relevant data dispersed throughout the literature concerning the genotypic evidences that support niche-specific phenotypes. This review focus on chromosomal dynamics phenomena like recombination and point-mutations, essentially involving outer and inclusion membrane proteins, type III secretion effectors, and hypothetical proteins with unknown function. The scrutiny of C trachomatis loci involved in tissue tropism, pathogenesis and ecological success is crucial for the development of disease-specific prophylaxis. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:392 / 400
页数:9
相关论文
共 50 条
  • [31] Maternal age and chromosomally abnormal pregnancies: what we know and what we wish we knew
    Hassold, Terry
    Hunt, Patricia
    CURRENT OPINION IN PEDIATRICS, 2009, 21 (06) : 703 - 708
  • [32] Immune response in COVID-19: What do we currently know?
    Oliveira, Daniela S.
    Medeiros, Nayara I.
    Gomes, Juliana A. S.
    MICROBIAL PATHOGENESIS, 2020, 148
  • [33] Drivers and Distribution of Henipavirus-Induced Syncytia: What Do We Know?
    Gamble, Amandine
    Yeo, Yao Yu
    Butler, Aubrey A.
    Tang, Hubert
    Snedden, Celine E.
    Mason, Christian T.
    Buchholz, David W.
    Bingham, John
    Aguilar, Hector C.
    Lloyd-Smith, James O.
    VIRUSES-BASEL, 2021, 13 (09):
  • [34] Just What Do We Know About Corneal Collagen Turnover? Reply
    Mazzotta, Cosimo
    CORNEA, 2018, 37 (11) : E51 - E52
  • [35] Growing pains: What do we know about etiology? A systematic review
    Pavone, Vito
    Vescio, Andrea
    Valenti, Fabiana
    Sapienza, Marco
    Sessa, Giuseppe
    Testa, Gianluca
    WORLD JOURNAL OF ORTHOPEDICS, 2019, 10 (04): : 192 - 205
  • [36] Iron Deficiency Anemia in Inflammatory Bowel Disease: What Do We Know?
    Resal, Tamas
    Farkas, Klaudia
    Molnar, Tamas
    FRONTIERS IN MEDICINE, 2021, 8
  • [37] Meniscal translation during knee flexion: what do we really know?
    Corey Scholes
    Eleanor R. Houghton
    Matthew Lee
    Sebastien Lustig
    Knee Surgery, Sports Traumatology, Arthroscopy, 2015, 23 : 32 - 40
  • [38] Meniscal translation during knee flexion: what do we really know?
    Scholes, Corey
    Houghton, Eleanor R.
    Lee, Matthew
    Lustig, Sebastien
    KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, 2015, 23 (01) : 32 - 40
  • [39] WHAT DO WE REALLY KNOW ABOUT AMYOTROPHIC-LATERAL-SCLEROSIS
    SWASH, M
    SCHWARTZ, MS
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1992, 113 (01) : 4 - 16
  • [40] Pathophysiology of long-term complications in classic galactosemia: What we do and do not know
    Fridovich-Keil, Judith L.
    Berry, Gerard T.
    MOLECULAR GENETICS AND METABOLISM, 2022, 137 (1-2) : 33 - 39